Alpine Global Management LLC Makes New Investment in Corteva, Inc. $CTVA

Alpine Global Management LLC purchased a new stake in Corteva, Inc. (NYSE:CTVAFree Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 8,827 shares of the company’s stock, valued at approximately $597,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in CTVA. Empirical Finance LLC increased its position in Corteva by 0.6% in the 2nd quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after buying an additional 153 shares in the last quarter. Fox Run Management L.L.C. boosted its holdings in Corteva by 5.1% in the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock worth $227,000 after acquiring an additional 164 shares in the last quarter. IFG Advisory LLC grew its stake in Corteva by 1.7% in the third quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock valued at $660,000 after acquiring an additional 166 shares during the period. Kelleher Financial Advisors grew its stake in Corteva by 3.8% in the third quarter. Kelleher Financial Advisors now owns 4,594 shares of the company’s stock valued at $311,000 after acquiring an additional 170 shares during the period. Finally, United Community Bank increased its holdings in shares of Corteva by 10.5% during the third quarter. United Community Bank now owns 1,849 shares of the company’s stock valued at $125,000 after acquiring an additional 176 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 1.3%

Shares of CTVA opened at $80.06 on Wednesday. The firm’s 50 day simple moving average is $74.55 and its 200 day simple moving average is $69.24. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The company has a market capitalization of $53.84 billion, a P/E ratio of 50.67, a P/E/G ratio of 2.70 and a beta of 0.72. Corteva, Inc. has a 1-year low of $53.40 and a 1-year high of $80.90.

Corteva (NYSE:CTVAGet Free Report) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same period last year, the business earned $0.32 earnings per share. The business’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date was Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CTVA. Mizuho increased their target price on Corteva from $80.00 to $82.00 and gave the stock an “outperform” rating in a report on Tuesday, February 17th. Zacks Research lowered shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. The Goldman Sachs Group restated a “buy” rating and set a $88.00 price objective on shares of Corteva in a report on Thursday, February 5th. Wolfe Research lifted their price objective on shares of Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Finally, Bank of America boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Thursday, January 8th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

View Our Latest Report on Corteva

Insiders Place Their Bets

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.15% of the company’s stock.

About Corteva

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Read More

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVAFree Report).

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.